MedicarePartD.guide

A non-government resource built from CMS public data

Tremfya on HealthSpring Extra Rx (S5617-368)

guselkumab

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 2 per 28 days.

$3,642.30
Patient pays / month, after deductible
$4,103.55
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

TREMFYA 200 mg/2mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $14,569.21 for a month. Other covered strengths are listed below.

Prior authRequired on all 5 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
FormTierPatient pays / monthLimits
TREMFYA 100 mg/mL Injection5$6,965.78PA · 2 per 28 days
TREMFYA 100 mg/mL Injection5$6,977.91PA · 2 per 28 days
TREMFYA 200 mg/2mL Injection5$3,642.30PA · 2 per 28 days
TREMFYA 200 mg/2mL Injection5$3,642.30PA · 24 per 365 days
TREMFYA 200 mg/2mL Injection5$3,642.30PA · 2 per 28 days

Other IL-17 and IL-23 biologics on this plan

Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5617-368